A Patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of Hyperglycemia

A 77-year-old-man with renal cell carcinoma who was undergoing nivolumab treatment visited our department due to hyperglycemia; his plasma glucose level was 379 mg/dL. Although his serum C-peptide immunoreactivity (CPR) level was preserved (5.92 ng/mL), we suspected an onset of fulminant type 1 diab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Yamamoto, Naoko, Tsurutani, Yuya, Katsuragawa, Sho, Kubo, Haremaru, Sunouchi, Takashi, Hirose, Rei, Hoshino, Yoshitomo, Ichikawa, Masahiro, Takiguchi, Tomoko, Yukawa, Hiroko, Arioka, Hitoshi, Saitou, Jun, Nishikawa, Tetsuo
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815891/
https://ncbi.nlm.nih.gov/pubmed/31243198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2780-19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados